ALKBH5 suppresses malignancy of hepatocellular carcinoma via m(6)A-guided epigenetic inhibition of LYPD1

BACKGROUND: N6-methyladenosine (m(6)A) modification is an emerging layer of epigenetic regulation which is widely implicated in the tumorigenicity of hepatocellular carcinoma (HCC), offering a novel perspective for investigating molecular pathogenesis of this disease. The role of AlkB homolog 5 (ALK...

詳細記述

保存先:
書誌詳細
出版年:Mol Cancer
主要な著者: Chen, Yunhao, Zhao, Yanchun, Chen, Junru, Peng, Chuanhui, Zhang, Yanpeng, Tong, Rongliang, Cheng, Qiyang, Yang, Beng, Feng, Xiaode, Lu, Yuejie, Xie, Haiyang, Zhou, Lin, Wu, Jian, Zheng, Shusen
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2020
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7416417/
https://ncbi.nlm.nih.gov/pubmed/32772918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-020-01239-w
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料